Five things for pharma marketers to know: Tuesday, August 4, 2020
Group petitions FDA to ban music in drug ads; GSK, Sanofi under investigation over heartburn carcinogens; Eli Lilly begins COVID-19 study in nursing homes.
News
Health Media in the COVID-19 Era: A mid-wave report
As the country slinks into its sixth month of battle against the novel coronavirus, health media experts assess coverage hits and misses.
Five things for pharma marketers to know: Monday, August 3, 2020
U.S. to pay $2.1 billion for Sanofi and GSK vaccines; COVID-19 clinical trials are not diverse; Merck to begin late-stage studies of its coronavirus treatment in September.
Walter Geer joins VMLY&R as executive creative director
Geer was previously SVP and group creative director at TBWA\WorldHealth.
Five things for pharma marketers to know: Friday, July 31, 2020
Young people and long-term COVID-19 symptoms; Juul files application to sell products; FDA: Vaccine can be approved if 50% effective.
The Escalator: Greater Than One names Hoon Chang chief client officer
Plus people moves at MiMedx and Micron Medical.
Five things for pharma marketers to know: Thursday, July 30, 2020
GSK begins trials of cancer drug found through 23andMe partnership; Roche arthritis drug fails COVID-19 trial; U.S. coronavirus deaths surpass 150,000.
‘He knew more about comms than I did about epidemiology.’ Former HHS press secretary on efforts to sideline Fauci and the way forward
Communicators inside the White House would do well to stop maligning public health experts, for the sake of the country and their own credibility, says a former HHS press officer.
Imre appoints Amag’s Blake Schiller pharma and biotech lead
Schiller joined the agency from Amag Pharmaceuticals.
Coronavirus Briefing: Vaccine optimism, GOP’s stimulus and MLB in crisis
This week’s Haymarket Media Coronavirus Briefing is 1,202 words and will take you 6 minutes to read.
Want to read more?
Please login or register first to view this content.
